Neostigmine Methylsulfate | JP | Pharmacopoeia | Reference Standards| PharmaCompass.com

Please Wait

Applying Filters...

Neostigmine Methylsulfate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 10 USDMF, 6 CEP/COS, 2 JDMF, 11 EU WC, 11 NDC API, 15 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

71 FDF Dossiers, 42 FDA Orange Book, 1 Europe, 8 Canada, 2 South Africa, 18 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;INTRAVENOUS - 10MG/10ML (1MG/ML), SOLUTION;INTRAVENOUS - 3MG/3ML (1MG/ML), SOLUTION;INTRAVENOUS - 5MG/10ML (0.5MG/ML), SOLUTION;INTRAVENOUS - 10MG/10ML (1MG/ML), SOLUTION;INTRAVENOUS - 5MG/10ML (0.5MG/ML), SOLUTION;INTRAVENOUS - 5MG/5ML (1MG/ML)

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 32 News #PharmaBuzz

MARKET PLACE

9 APIs, 1 FDF Dossiers

REF. STANDARDS & IMPURITIES

1 USP, 3 JP, 1 Others

$ Xls

Filters

Filters

FILTER :

filter Reference Standard Reset all filters

3 All

01 3Neostigmine Methylsulfate

filter Monograph in Japanese Pharmacopoeia Reset all filters

Product Main Page

01

Japanese Pharmacopoeia

Japan

ICHH-25

Not Confirmed

02

Japanese Pharmacopoeia

Japan

ICHH-25

Not Confirmed

03

Japanese Pharmacopoeia

Japan

ICHH-25

Not Confirmed

Contact us
to update this info